Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hawe

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2002
Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of EuropeI Juhan-Vague, P E Morange, H Aubert, et al.
Thrombosis and Haemostasis|November 16, 2004
Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH StudyDaniel Kelberman, E Hawe, L A Luong, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2003
The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH studyI Juhan-Vague, P E Morange, C Frere, et al.
Atherosclerosis|June 1, 2005
EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitroH Ireland, C J Konstantoulas, J A Cooper, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2002
Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of EuropeI Juhan-Vague, P E Morange, H Aubert, et al.
Thrombosis and Haemostasis|November 16, 2004
Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH StudyDaniel Kelberman, E Hawe, L A Luong, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2003
The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH studyI Juhan-Vague, P E Morange, C Frere, et al.
Atherosclerosis|June 1, 2005
EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitroH Ireland, C J Konstantoulas, J A Cooper, et al.
Pageof 3